Propanc Biopharma PPCB
NASDAQ PPCB
$0.49 -0.02 (-3.92%)
At close: Sep 30, 2026 · 4:00 PM EDT

Propanc Biopharma (PPCB) Return on Equity [ROE] (2011 - 2025)

Updated

Propanc Biopharma (PPCB) reported Return on Equity [ROE] of -161.86% for FY2026 (year ended Jun 30, 2026), up 1001.81 percentage points from -1163.67% in FY2025.

Analysis

Propanc Biopharma (PPCB) Return on Equity [ROE] (2011 - 2025) Analysis & Trends

  • According to Business Quant data, Return on Equity [ROE] came in at -1163.67% in FY2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.32%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 7.21%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 84.40%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 21.39%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 83.75%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -18.38%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.97%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 22.24%
10 Propanc Biopharma 550,617.42 550,617.42 - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -532.52%
Sep 30, 2025 -448.62%
Jun 30, 2025 -368.29%
Mar 31, 2025 -792.48%
Jun 30, 2012 -2,006.89%
Mar 31, 2012 -307.71%
Dec 31, 2011 -92.42%
API Access

Propanc Biopharma Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PPCB&period=max&api_key=YOUR_API_KEY